Environment &
Food & Beverage
Cosmetics
Life Sciences
Metal & Mining Industry
Petrochemical & General Chemistry
Automotive Related & Interior Materials
Applications including "Pharmaceutical"
-
LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -
LC Technical Note InertSustain AQ-C18 InertSustain PFP -
GA113 - Residual solvents in pharmaceuticals -
GC InertSearch InertCap Pure-WAX -
GA397 - Analysis of Nitromethane(Under the Condition of draft for USP, Tromethamine Hydrochloride, Limit of Nitromethane) -
GC InertSearch InertCap 624MS -
LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -
LC InertSearch InertSustain AQ-C18 -
LC109 - Analysis of Prazosin hydrochloride (Under the Condition of draft for USP, Prazosin Hydrochloride Compounded Oral Suspension, ASSAY) -
LC InertSearch InertSustainC18 -
LC108 - Analysis of Formoterol fumarate (Under the Condition of draft for USP, Formoterol Fumarate Inhalation Solution, Assay) -
LC InertSearch InertCore C8 -
LC107 - Analysis of Terbinafine hydrochloride (Under the Condition of USP41-NF36,Terbinafine Tablets, IMPURITIES (LIMIT OF TERBINAFINE DIMER)) -
LC InertSearch Inertsil Hybrid-C18 -
LC105 - Analysis of Cefalexin (Under the Condition of Japanese Pharmacopoeia 18th, Cefalexin,Purity(3) Related substances ) -
LC InertSearch InertSustainSwift C18 -
LC100 - Analysis of Omeprazole(Under the Condition of USP41-NF36, Omeprazole Delayed-Release Capsules, ASSAY) -
LC InertSearch InertSustain C8 -
LL043 - Analysis of Azithromycin (Based on the Condition of USP-NF 2025 Issue 2 Mar, Azithromycin Tablets, ORGANIC IMPURITIES) -
LC InertSearch Inertsil Hybrid-C18 -
LC099 - Analysis of Ascorbic acid (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels, Ascorbic acid, Method 1) -
LC InertSearch InertSustain C8 -
LC098 - Analysis of Tramadol Hydrochloride (Under the Condition of draft for USP, Tramadol Hydrochloride Tablets, ASSAY) -
LC InertSearch InertSustain C8 -
LC097 - Analysis of Azithromycin (Based on the Condition of USP NF 2025 Issue 2 Mar, Azithromycin Tablets, ORGANIC IMPURITIES) -
LC InertSearch Inertsil Hybrid-C18 -
LC096 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ORGANIC IMPURITIES) -
LC InertSearch InertSustainSwift C18 -
LC095 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ASSAY) -
LC InertSearch InertSustainSwift C18 -
LC094 - Analysis of Steroids -
LC InertSearch Inertsil Hybrid-C18 -
LC093 - Analysis of Phytosterols -
LC InertSearch Inertsil Hybrid-C18 -
LC092 - Analysis of Oligonucleotides -
LC InertSearch Inertsil Hybrid-C18 -
LC091 - Analysis of Oligonucleotides -
LC InertSearch Inertsil Hybrid-C18 -
LC090 - Analysis of Oligonucleotides -
LC InertSearch Inertsil Hybrid-C18 -
LC089 - Analysis of Nucleobases and Nucleosides -
LC InertSearch Inertsil Hybrid-C18 -
LC088 - Analysis of Nucleobases and Nucleosides -
LC InertSearch Inertsil Hybrid-C18 -
LC087 - Analysis of Coenzyme A (CoA) -
LC InertSearch Inertsil Hybrid-C18 -
LC086 - Analysis of Antiviral drugs -
LC InertSearch Inertsil Hybrid-C18 -
LC085 - Analysis of Antiviral drug nucleosides -
LC InertSearch Inertsil Hybrid-C18 -
LC084 - Analysis of Antihistamines -
LC InertSearch Inertsil Hybrid-C18 -
LC083 - Analysis of Antidepressants -
LC InertSearch Inertsil Hybrid-C18 -
LC082 - Analysis of phytosterols -
LC InertSearch InertCore Plus C18 -
LC080 - Analysis of Nucleobases and Nucleosides -
LC InertSearch InertCore Biphenyl -
LC079 - Analysis of Decitabine -
LC InertSearch InertCore Biphenyl -
LC073 - Analysis of Yohimbine Hydrochloride(Under the Condition of USP41-NF36,Yohimbine Injection, ASSAY) -
LC InertSearch InertSustain C18 -
LC072 - Analysis of Vitamin K１ (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PHYTONADIONE) -
LC InertSearch InertSustain C18 -
LC071 - Analysis of Acetaminophen(Under the Condition of USP41-NF36, Acetaminophen Oral Solution, ASSAY) -
LC InertSearch Inertsil WP300 C18 -
LC070 - Analysis of Vitamin A (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Vitamin A,Method 1) -
LC InertSearch InertSustain NH2 -
LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -
LC InertSearch Inertsil WP300 C18 -
LC067 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia 18th, Rebamipide, Purity (4) Related Substances -
LC InertSearch Inertsil ODS-3 -
LC066 - Analysis of Cidofovir (Under the Condition of USP43-NF38, Cidofovir, ASSAY) -
LC InertSearch Inertsil Hybrid-C18 -
LC065 - Analysis of Vitamin E (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 1) -
LC InertSearch InertSustain C18 -
LC064 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(2)Glimepiride) -
LC InertSearch InertSustainSwift C18 -
LC063 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(1)Pioglitazone Hydrochloride) -
LC InertSearch InertSustainSwift C18 -
LC062 - Analysis of Azithromycin (Under the Condition of USP NF 2025 Issue 2 Mar, Azithromycin, DISSOLUTION) -
LC InertSearch Inertsil Hybrid-C18 -
LC061 - Analysis of Azithromycin (Under the Condition of USP NF 2025 Issue 2 Mar, Azithromycin,ASSAY) -
LC InertSearch Inertsil Hybrid-C18 -
LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -
LC InertSearch InertSustain C18 -
LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -
LC InertSearch InertSustain AQ-C18 -
LC058 - Analysis of Folic acid (Under the Condition of USP NF 2022 ISSUE 3, <411>FOLIC ACID ASSAY,_Procedure 1) -
LC InertSearch InertSustainSwift C18 -
LC057 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Tablets, ASSAY) -
LC InertSearch InertSustain C18 -
LC056 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol, ASSAY) -
LC InertSearch InertSustain C18 -
LC055 - Analysis of Dobutamine (Under the Condition of the USPNF 2023 Issue 2, Dobutamine Hydrochloride, ASSAY) -
LC InertSearch Inertsil WP300 C18 -
LC054 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Injection, ASSAY) -
LC InertSearch InertSustain C18 -
LC053 - Analysis of Folic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,FOLIC ACID_Method 2) -
LC InertSearch InertSustain C8 -
LC052 - Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 2) -
LC InertSearch InertSustain C8 -
LC051 - Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 1) -
LC InertSearch InertSustain AQ-C18 -
LC050 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 3) -
LC InertSearch Inertsil WP300 C18 -
LC049 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 2) -
LC InertSearch InertSustain C18 -
LC043 - Analysis of Semaglutide and Tirzepatide -
LC InertSearch InertSustainSwift C18 -
LC042 - Analysis of Nicotinic acid,Pyridoxine Hydrochloride,Riboflavin,and Thiamine hydrochloride_Method3 (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin or Niacinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine_ Method3) -
LC InertSearch InertSustain C8 -
LC041 - Analysis of Nicotinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine hydrochloride_Method1 (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin or Niacinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine_ Method1) -
LC InertSearch InertSustain C18 -
LC040 - Analysis of Acetaminophen (Under the Condition of the USPNF2023 Issue 1, Acetaminophen, IMPURITIES, Limit of Free 4-Aminophenol) -
LC InertSearch InertSustainSwift C8 -
LC039 - Analysis of Acetaminophen (Under the Condition of the USPNF2023 Issue 1, Acetaminophen, ASSAY) -
LC InertSearch InertSustainSwift C8 -
LC037 - Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) -
LC InertSearch InertSustain C18 -
LC036 - Analysis of Zonisamide (Under the Condition of USP41-NF36, Zonisamide Compounded Oral Suspension, ASSAY) -
LC InertSearch InertSustain C18 -
LC035 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide Capsules, ASSAY) -
LC InertSearch InertSustain C18 -
LC034 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide, ASSAY) -
LC InertSearch InertSustain C18 -
LC033 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Oil- and Water-Soluble Vitamins Minerals Tablets,BIOTIN_Method 3) -
LC InertSearch InertSustain C18 -
LC032 - Analysis of D‐Biotin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,BIOTIN_Method 1) -
LC InertSearch InertSustain C8 -
LC031 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Biotin) -
LC InertSearch InertSustain C8 -
LC030 - Analysis of Piperazine anhydrous -
LC InertSearch InertSustain Amide -
LC029 - Analysis of Riboflavin (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,RIBOFLAVIN_Method 2) -
LC InertSearch InertSustain C18 -
LC028 - Analysis of Pyridoxine hydrochloride (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PYRIDOXINE HYDROCHLORIDE_Method 2) -
LC InertSearch InertSustain C18 -
LC027 - Analysis of Nicotinamide (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,NIACINAMIDE_Method 2) -
LC InertSearch InertSustain C18 -
LC026 - Analysis of Nicotinic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin_Method 2) -
LC InertSearch InertSustain C18 -
LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -
LC InertSearch InertSustain AQ-C18 -
LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -
LC InertSearch Inertsil ODS-3 -
LC023 - Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) -
LC InertSearch InertSustain C18 -
LC022 - Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) -
LC InertSearch InertSustain C18 -
LC021 - Analysis of Cyanocobalamin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Cyanocobalamin_Method1) -
LC InertSearch Inertsil ODS-HL -
LC020 - Analysis of D(-)-Mannitol -
LC InertSearch InertSphere FA-1 -
LC017 - Analysis of Itraconazole (Under the Condition of Japanese Pharmacopoeia 18th, Itraconazole, Purity(2) Related substances) -
LC InertSearch InertSustain C18 -
LC016 - Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) -
LC InertSearch InertSustain C18 -
LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -
LC InertSearch InertSustain C18 -
LC014 - Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) -
LC InertSearch InertSustainSwift C18 -
LC013 - Analysis of Bleomycin sulfate -
LC InertSearch InertSustain AQ-C18 -
LC011 - Analysis of Spectinomycin -
LC InertSearch InertSustain C8 -
GA387 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -
GC InertSearch InertCap FFAP -
LC009 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -
LC InertSearch Inertsil ODS-3 -
LC008 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -
LC InertSearch InertSustain C18 -
LC007 - Analysis of Olanzapine -
LC InertSearch InertSustain C8 -
GA386 - Analysis of Fatty acid methyl ester -
GC InertSearch InertCap Pure-WAX -
GA385 - Analysis of Palmitic acid and 2-Ethylhexanoic acid -
GC InertSearch InertCap FFAP -
LC005 - Carbamazepine -
LC InertSearch InertSustainSwift C18 -
GA384 - 1,2-Octanediol -
GC InertSearch InertCap 17 -
LC002 - Analysis of Phenazopyridine hydrochloride -
LC InertSearch InertSustain C18 -
LB998 - Analysis of Dextrose -
LC InertSearch InertSphere Sugar-2 -
LB997 - Analysis of Mesalamine -
LC InertSearch InertSustain C8 -
LB996 - Analysis of Mesalamine -
LC InertSearch InertSustain C8 -
LB995 - Analysis of Mesalamine -
LC InertSearch InertSustain C8 -
LB994 - Analysis of Mesalamine -
LC InertSearch InertSustain C8 -
LB993 - Analysis of Theophylline -
LC InertSearch InertSustainSwift C8 -
LB991 - Analysis of Progestrone and Methyltestrone -
LC InertSearch Inertsil WP300 C18 -
LB990 - Analysis of Xylazine -
LC InertSearch Inertsil WP300 C18 -
LB989 - Analysis of Xylazine -
LC InertSearch InertSustain C18 -
LB988 - Analysis of Xylazine -
LC InertSearch InertSustainSwift C8 -
LB987 - Analysis of Xylazine -
LC InertSearch Inertsil WP300 C18 -
LB986 - Analysis of Ganciclovir -
LC InertSearch Inertsil ODS-3 -
LB985 - Analysis of Sumatriptan -
LC InertSearch Inertsil ODS-3 -
LB984 - Analysis of Sumatriptan -
LC InertSearch InertSustain AQ-C18 -
LB983 - Analysis of Lornoxicam -
LC InertSearch Inertsil ODS-4 -
LB982 - Analysis of Ofloxacin -
LC InertSearch InertSustain C18 -
LB981 - Analysis of Ofloxacin -
LC InertSearch Inertsil WP300 C18 -
LB980 - Analysis of Desloratadine -
LC InertSearch InertSustain AQ-C18 -
LB979 - Analysis of Desloratadine -
LC InertSearch InertSustain Cyano -
LB978 - Analysis of Hydrochlorothiazide -
LC InertSearch InertSustain AQ-C18 -
LB977 - Analysis of Dapagliflozin propandiol -
LC InertSearch InertSustain AQ-C18 -
LB976 - Analysis of Dapagliflozin propandiol -
LC InertSearch InertSustain C18 -
LB975 - Analysis of Dapagliflozin propandiol -
LC InertSearch InertSustain C18 -
LB974 - Analysis of Dapagliflozin propandiol -
LC InertSearch InertSustain C18 -
LB973 - Analysis of Dapagliflozin propandiol -
LC InertSearch InertSustain C18 -
LB972 - Analysis of Acyclovir -
LC InertSearch InertSustain C18 -
LB971 - Analysis of Acyclovir -
LC InertSearch InertSustain C18 -
LB970 - Analysis of Acyclovir -
LC InertSearch InertSustain C18 -
LB969 - Analysis of Acyclovir -
LC InertSearch InertSustainSwift C18 -
LB968 - Analysis of Acyclovir -
LC InertSearch Inertsil WP300 C18 -
LB965 - Analysis of Nicardipine Hydrochloride -
LC InertSearch InertSustain C8 -
LB961 - Analysis of Lidocaine -
LC InertSearch Insertsil WP300 C18 -
LB960 - Analysis of Lidocaine -
LC InertSearch Insertsil WP300 C18 -
GA381 - Analysis of Residual solvents in pharmaceuticals (Class 3) -
GC InertSearch InertCap Pure-WAX -
GA380 - Analysis of Residual solvents in pharmaceuticals (Class 3) -
GC InertSearch InertCap 624MS -
LB958 - Analysis of Methyltestosterone and Progesterone -
LC InertSearch Insertsil WP300 C18 -
LB956 - Analysis of Sumatriptan succinate and Naproxen Sodium -
LC InertSearch Insertsil Ph-3 -
GA375 - Analysis of Residual solvents in pharmaceuticals (Class 2E) -
GC InertSearch InertCap Pure-WAX -
GA374 - Analysis of Residual solvents in pharmaceuticals (Class 2E) -
GC InertSearch InertCap 624MS -
GA373 - Analysis of Residual solvents in pharmaceuticals (Class 2E) -
GC InertSearch InertCap 624MS -
GA372 - Analysis of Residual solvents in pharmaceuticals (Class 2D) -
GC InertSearch InertCap Pure-WAX -
GA371 - Analysis of Residual solvents in pharmaceuticals (Class 2D) -
GC InertSearch InertCap 624MS -
GA370 - Analysis of Residual solvents in pharmaceuticals (Class 2D) -
GC InertSearch InertCap 624MS -
LB953 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets, Pregabalin Capsules) -
LC InertSearch InertSustain Cyano -
LB952 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets) -
LC InertSearch InertSustain C18 -
LB951 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Capsules) -
LC InertSearch InertSustain C18 -
LB950 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin) -
LC InertSearch InertSustain C18 -
LB948 - Analysis of Omeprazole -
LC InertSearch Inertsil C8-3 -
LB946 - Analysis of Glacial Acetic Acid -
LC InertSearch InertSustain AQ-C18 -
LB945 - Analysis of Glacial Acetic Acid -
LC InertSearch InertSustain AQ-C18 -
LB944 - Analysis of Amikacin sulfate -
LC InertSearch InertSustainSwift C18 -
LB943 - Analysis of Amikacin -
LC InertSearch InertSustainSwift C18 -
LB942 - Analysis of Maleic acid -
LC InertSearch Inertsil ODS-4 -
LB941 - Analysis of Fumaric acid -
LC InertSearch Inertsil ODS-4 -
LB940 - Analysis of DL-Malic acid -
LC InertSearch InertSustain C18 -
LB939 - Analysis of Potassium sucrose octasulfate -
LC InertSearch Inertsil NH2 -
LB938 - Analysis of Galantamine -
LC InertSearch InertSustain C18 -
LB937 - Analysis of Febuxostat -
LC InertSearch Inertsil ODS-4 -
LB936 - Analysis of Febuxostat -
LC InertSearch InertSustain C30 -
LB935 - Analysis of Febuxostat -
LC InertSearch InertSustain AQ-C18 -
LB934 - Analysis of Methylpyrazines -
LC InertSearch InertSustain C18 -
LB933 - Analysis of Diclofenac sodium -
LC InertSearch Inertsil WP300 C18 -
LB931 - Analysis of Acyclovir -
LC InertSearch Inertsil ODS-3 -
LB930 - Analysis of Blonanserin -
LC InertSearch InertSustain C18 -
LB929 - Analysis of Blonanserin -
LC InertSearch InertSustain C18 -
LB928 - Analysis of Blonanserin -
LC InertSearch InertSustain C18 -
LB927 - Analysis of Blonanserin -
LC InertSearch InertSustain C18 -
LB926 - Analysis of Piperacillin Sodium -
LC InertSearch Inertsil WP300 C18 -
LB925 - Analysis of Acyclovir -
LC InertSearch InertSustain Cyano -
LB924 - Analysis of Acyclovir -
LC InertSearch InertSustain Cyano -
LB922 - Analysis of 4 Drugs -
LC InertSearch InertSustai AQ-C18 InertSustain AQ-C18 -
LB921 - Analysis of 4 Drugs -
LC InertSearch Inertsil ODS-4 -
LB920 - Analysis of Triphenylphosphine oxide -
LC InertSearch InertSustain C18 -
LB919 - Analysis of Pitavastatin Calcium -
LC InertSearch InertCore Plus C18 -
LB916 - Analysis of Metformin Hydrochloride -
LC InertSearch InertSustain C18 -
LB915 - Analysis of Metformin Hydrochloride -
LC InertSearch InertSustain C18 -
LB914 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 -
LB913 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 -
LB912 - Analysis of Metformin Hydrochloride -
LC InertSearch Inertsil WP300 C18 -
LB911 - Analysis of Metformin Hydrochloride -
LC InertSearch Inertsil WP300 C18 -
LB907 - Analysis of Aripiprazole -
LC InertSearch InertSustain C18 -
LB906 - Analysis of Aripiprazole -
LC InertSearch InertSustain C18 -
LB905 - Analysis of Aripiprazole -
LC InertSearch InertSustain C18 -
LB904 - Analysis of Celecoxib -
LC InertSearch Inertsil Ph-3 -
LB903 - Analysis of Perospirone hydrochloride -
LC InertSearch InertSustain C18 -
LB902 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 -
LB901 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 -
LB900 - Analysis of Fesoterodine Fumarate -
LC InertSearch InertSustain C8 -
LB899 - Analysis of Fesoterodine Fumarate -
LC InertSearch InertSustainSwift C18 -
LL042 - Analysis of Ivermectin -
LC InertSearch InertSustain PFP -
GA351 - Analysis of Dextran 40 -
GC InertSearch InertCap 1 -
GA350 - Analysis of Acrylic Acid and Methyl Methacrylate -
GC InertSearch InertCap 1 -
LB896 - Analysis of Triptorelin Pamoate -
LC InertSearch InertSustain C18 -
LB895 - Analysis of Venlafaxine hydrochloride -
LC InertSearch InertSustainSwift C8 -
LB894 - Analysis of Ursodiol -
LC InertSearch Inertsil WP300 -
LB891 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 HP -
LB890 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 HP -
LB889 - Analysis of Propyl gallate -
LC InertSearch Inertsil WP300 -
LB888 - Analysis of Propyl gallate -
LC InertSearch Inertsil WP300 -
LB887 - Analysis of Propyl gallate -
LC InertSearch Inertsil ODS-4 -
LB885 - Analysis of Voriconazole -
LC InertSearch InertSustain C18 -
LB884 - Analysis of Voriconazole -
LC InertSearch InertSustain C18 -
LB883 - Analysis of Paclitaxel -
LC InertSearch InertSustain PFP -
LB882 - Analysis of Paracetamol and Mefenamic acid -
LC InertSearch InertSustain C18 -
LB881 - Analysis of Paracetamol and Mefenamic acid -
LC InertSearch Inertsil ODS-3 -
LB880 - Analysis of Paracetamol and Mefenamic acid -
LC InertSearch InertSustain C18 -
LB879 - Analysis of Paracetamol and Mefenamic acid -
LC InertSearch Inertsil ODS-3 -
LB878 - Analysis of Mefenamic acid -
LC InertSearch InertSustain C18 -
LB877 - Analysis of Mefenamic acid -
LC InertSearch Inertsil ODS-3 -
LB876 - Analysis of Cefoxitin -
LC InertSearch InertSustain C18 -
LB875 - Analysis of Levofloxacin -
LC InertSearch Inertsil ODS-3 -
LB874 - Analysis of Captopril and Captopril Disulfide -
LC InertSearch InertSustain AQ-C18 -
LB873 - Tacrolimus Extended-Release Capsules -
LC InertSearch InertSustain AQ-C18 -
LB872 - Analysis of Febuxostat -
LC InertSearch InertSustain Phenyl -
LB871 - Analysis of Febuxostat -
LC InertSearch InertSustain Phenyl -
LB870 - Analysis of Febuxostat -
LC InertSearch InertSustain Phenyl -
LB867 - Analysis of Febuxostat -
LC InertSearch InertSustain C18 -
LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -
LC InertSearch Inertsil ODS-4 -
LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -
LC InertSearch Inertsil ODS-4 -
LB837 - Analysis of Nonsteroidal anti-inflammatory drug -
LC InertSearch InertSustain C30 -
LB827 - Analysis of Clobetasone butyrate standard -
LC InertSearch InertSustainSwift C18 -
LB823 - Analysis of Glycyrrhiza -
LC InertSearch Inertsil ODS-3 -
LB816 - Analysis of Zoledronic acid -
LC InertSearch InertSustainSwift C18 -
LB815 - Analysis of Riboflavin (Vitamin B2) and its metabolites -
LC InertSearch InertSustainSwift C18 -
LB814 - Analysis of Coenzyme A (CoA) -
LC InertSearch InertSustain AQ-C18 -
LB806 - Analysis of Ampicillin and Sulbactam (Under the Condition of the Japanese Pharmacopoeia 18th , Ampicillin Sodium and Sulbactam Sodium for Injection) -
LC InertSearch Inertsil ODS-HL -
LB804 - Analysis of Metformin -
LC InertSearch Inertsil CX -
LB803 - Simultaneous analysis of Amino acids derivatized with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) -
LC InertSearch InertSustain C30 -
LB789 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB788 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB787 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB786 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB779 - Analysis of Coenzyme A (CoA) -
LC InertSearch InertSustain AX-C18 -
LB778 - Analysis of Coenzyme A (CoA) -
LC InertSearch InertSustain AX-C18 -
LB773 - Analysis of Nicotinamide adenine dinucleotide and Nicotinamide adenine dinucleotide phosphate (NAD+, NADH, NADP+, NADPH) -
LC InertSearch InertSustain AX-C18 -
LB772 - Analysis of Nicotinamide adenine dinucleotide (NADH, NAD+) -
LC InertSearch InertSustain AX-C18 -
LB771 - Analysis of Nucleoside and Nucleic acid base -
LC InertSearch InertSustain AX-C18 -
LB769 - Analysis of Thiamine and Thiamine pyrophosphate -
LC InertSearch InertSustain AX-C18 -
LB768 - Analysis of Low molecular weight Hyaluronic acid -
LC InertSearch InertSustain AX-C18 -
LB767 - Analysis of Chondroitin Sulfate -
LC InertSearch InertSustain AX-C18 -
LB762 - Analysis of L-Cysteic acid -
LC InertSearch InertSustain AX-C18 -
LB761 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -
LC InertSearch Inertsil ODS-4 -
LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -
LC InertSearch InertSustain C18 -
LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -
LC InertSearch InertSustain AX-C18 -
LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -
LC InertSearch InertSustain C18 -
LB757 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -
LC InertSearch Inertsil ODS-4 -
LB756 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -
LC InertSearch Inertsil ODS-4 -
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -
LC InertSearch InertSustainSwift C18 -
LB754 - Analysis of Saccharin (Under the Condition of the Japanese Pharmacopoeia 18th, Saccharin Sodium Hydrate) -
LC InertSearch Inertsil WP300 C18 -
LB740 - Analysis of Acetaminophen -
LC InertSearch Inertsil ODS-3 -
LB739 - Analysis of Acetaminophen -
LC InertSearch Inertsil ODS-3 -
LB738 - Analysis of Remdesivir -
LC InertSearch InertSustain AX-C18 -
LB737 - Analysis of Favipiravir -
LC InertSearch InertSustain AX-C18 -
LB736 - Analysis of Antidepressants -
LC InertSearch InertSustain AX-C18 -
LB735 - Analysis of Antihistamines -
LC InertSearch InertSustain AX-C18 -
LB733 - Analysis of Water-soluble Vitamins -
LC InertSearch InertSustain AX-C18 -
LB730 - Analysis of Glutathione -
LC InertSearch InertSustain AX-C18 -
LB729 - Analysis of L-Cystine and L-Cysteine and L-Cysteic acid -
LC InertSearch InertSustain AX-C18 -
LB722 - Analysis of Ethenzamide -
LC InertSearch InertSustain C18 -
LB721 - Analysis of Acetaminophen -
LC InertSearch InertSustain C18 -
LB720 - Analysis of Acetylsalicilic acid -
LC InertSearch InertSustain C18 -
GA342 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -
GC InertSearch InertCap WAX -
GA341 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -
GC InertSearch InertCap WAX -
GA340 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -
GC InertSearch InertCap WAX -
GA339 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -
GC InertSearch InertCap 624MS -
GA338 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -
GC InertSearch InertCap 624MS -
GA337 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -
GC InertSearch InertCap 624MS -
LB702 - Analysis of ibuprofen -
LC InertSearch InertSustain C18 -
LB701 - Analysis of chlorpheniramine maleate -
LC InertSearch Inertsil ODS-4 -
LB700 - Analysis of acetaminophen -
LC InertSearch InertSustain C18 -
LB699 - Analysis of Refined Glucose (Japanese Pharmacopoeia 18th Edition, Glucose, Assay) -
LC InertSearch InertSphere Sugar-2 -
LB698 - Analysis of Neomycin Sulfate (European Pharmacopoeia 11.0th Edition, Purity Test) -
LC InertSearch InertSustain C18 -
LB692 - Analysis of Nitrosamines -
LC InertSearch InertSustain AQ-C18 -
LB691 - Analysis of Nitrosamines -
LC InertSearch InertSustain PFP -
GA333 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -
GC InertSearch InertCap WAX -
GA332 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -
GC InertSearch InertCap 624MS -
GA331 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -
GC InertSearch InertCap 624MS -
GA330 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -
GC InertSearch InertCap WAX -
GA329 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -
GC InertSearch InertCap 624MS -
GA328 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -
GC InertSearch InertCap 624MS -
GA327 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -
GC InertSearch InertCap WAX -
GA326 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -
GC InertSearch InertCap 624MS -
GA325 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -
GC InertSearch InertCap 624MS -
GA324 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -
GC InertSearch InertCap WAX -
GA323 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -
GC InertSearch InertCap 624MS -
GA322 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -
GC InertSearch InertCap 624MS -
LB690 - Analysis of Nitrosamines -
LC InertSearch InertSustain PFP -
GA319 - Residual solvents in pharmaceuticals (Class 3) -
GC InertSearch InertCap Pure-WAX -
GA318 - Residual solvents in pharmaceuticals (Class 3) -
GC InertSearch InertCap 624MS -
LT051 - Analysis of Allantoin in Cosmetics Using HILIC HPLC -
LC Technical Note Inertsil HILIC -
LL001 - Establishing an ECD(Electro Chemical Detector)-HPLC System Using a Unique Diamond Electrode High-precision Quantitative Analysis of SAA (Sulfur Amino Acids) -
LC InertSearch Inertsil ODS-3 -
LB564 - Analysis of Steviol glycosides (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract Assay) -
LC InertSearch Inertsil NH2 -
LB563 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -
LC InertSearch InertSustain AQ-C18 -
LB562 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -
LC InertSearch Inertsil ODS-HL -
LB542 - Analysis of D-Mannitol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), D-Mannitol and Corn starch compound) -
LC InertSearch InertSphere Sugar-2 -
LB312 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -
LC InertSearch InertSustain C18 -
LB311 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -
LC InertSearch Inertsil ODS-3 -
LB228 - Analysis of Polyvinyl alcohol, Polyethyleneglycol and Graft copolymer (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), (3) Acetic acid) -
LC InertSearch InertSustain C18 -
LB224 - Analysis of Tocopherol (InertSuatin C18) (Under the Condition of the Japanese Pharmaceutical Codex) -
LC InertSearch InertSustain C18 -
GT115 - Purity Test of Sucralose, Pharmaceutical Excipients Standard 2018 -
GC Technical Note InertCap 624MS -
GT036 - Analysis of Residual Solvent Components in Pharmaceutical Products - Using InertCap 5 -
GC Technical Note InertCap 5 -
GT035 - Analysis of Residual Solvent Components in Drugs - Using InertCap 624 -
GC Technical Note InertCap 624 -
GT023 - Analysis of Residual Solvent Components in Pharmaceutical Products ? Using InertCap Pure-WAX -
GC Technical Note InertCap Pure-WAX -
GA288 - Residual solvents in pharmaceuticals (Class 2B) -
GC InertSearch InertCap 624MS -
GA287 - Residual solvents in pharmaceuticals (Class 2A) -
GC InertSearch InertCap 624MS -
GA286 - Residual solvents in pharmaceuticals (Class 1) -
GC InertSearch InertCap 624MS -
GA281 - Residual solvents in pharmaceuticals -
GC InertSearch InertCap WAX -
GA153 - Ethanolamines -
GC InertSearch InertCap for Amines -
GA128 - Residual solvents in pharmaceuticals -
GC InertSearch InertCap 5 -
GA127 - Residual solvents in pharmaceuticals Class3 -
GC InertSearch InertCap 5 -
GA126 - Residual solvents in pharmaceuticals Class2 -
GC InertSearch InertCap 5 -
GA125 - Residual solvents in pharmaceuticals Class1 -
GC InertSearch InertCap 5 -
GA124 - Residual solvents in pharmaceuticals -
GC InertSearch InertCap 5 -
GA123 - Residual solvents in pharmaceuticals -
GC InertSearch InertCap 624 -
GA094 - Residual solvents in pharmaceuticals Class3 -
GC InertSearch InertCap Pure-WAX -
GA093 - Residual solvents in pharmaceuticals Class3 -
GC InertSearch InertCap 624 -
GA092 - Residual solvents in pharmaceuticals Class2 -
GC InertSearch InertCap Pure-WAX -
GA091 - Residual solvents in pharmaceuticals Class2 -
GC InertSearch InertCap 624 -
GA090 - Residual solvents in pharmaceuticals Class1 -
GC InertSearch InertCap Pure-WAX -
GA089 - Residual solvents in pharmaceuticals Class1 -
GC InertSearch InertCap 624